People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Biotechnology, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. | — | Biotechnology | Series D+ | $349.1M | $2.8B | 2014 |
| DiCE MOLECULES HOLDINGS, LLC | — | Other Technology | Series C | $158.8M | $1.3B | 2015 |
| DiCE Molecules Corp | — | Other | Seed | $2.9M | $53.9M | 2013 |
Kevin Judice at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin Judice on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Bedbrook | 2 | 3 |
| Pehr Harbury | 2 | 2 |
| Patrick Heron | 1 | 11 |
| Nina Kjellson | 1 | 11 |
| SCOTT ROCKLAGE | 1 | 9 |
| Michael Rubin | 1 | 8 |
| Jake Simson | 1 | 6 |
| Steve Elms | 1 | 4 |
| Jeffrey Stein | 1 | 4 |
| Shaan Gandhi | 1 | 4 |
| Sharon Tetlow | 1 | 4 |
| Scott M. Rocklage | 1 | 4 |
| Richard Scheller | 1 | 4 |
| Theodore R. Schroeder | 1 | 4 |
| Kevin Forrest | 1 | 3 |
| Dirk Thye | 1 | 3 |
| Daniel D. Burgess | 1 | 3 |
| Scott Robertson | 1 | 3 |
| Timothy R. Franson | 1 | 2 |
| Michael Rabson | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.